Status | Study |
Recruiting |
Study Name: Congenital Muscle Disease Study of Patient and Family Reported Medical Information Condition: Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed) Dystroglycanopathy Date: 2011-07-26 |
No longer available |
Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2011-06-20 Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Completed |
Study Name: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) Condition: Lambert Eaton Myasthenic Syndrome Date: 2011-06-17 Interventions: Drug: Amifampridine Phosphate |
No longer available |
Study Name: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome Condition: Lambert-Eaton Myasthenic Syndrome Date: 2011-06-13 Interventions: Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
Completed |
Study Name: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condition: Congenital Myasthenic Syndrome Date: 2010-09-15 Interventions: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
Study Name: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine Condition: Lambert-Eaton Myasthenic Syndrome Date: 2009-10-08 Interventions: Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |
Recruiting |
Study Name: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) Condition: Lambert-Eaton Myasthenic Syndrome Congenital Date: 2009-03-30 Interventions: Drug: 3,4-DIAMINOPYRIDINE Trea |
Available |
Study Name: Treatment of Lambert-Eaton Syndrome With 3,4 DAP Condition: Lambert Eaton Myasthenic Syndrome Date: 2008-06-23 Interventions: Drug: 3, 4 DAP Patients with clinically-confirmed LEMS will receive 3, 4 DAP by mouth in slowly increasi |
Completed |
Study Name: Ephedrine for the Treatment of Congenital Myasthenia Condition: Myasthenic Syndromes, Congenital Date: 2007-10-07 Interventions: Drug: Ephedrine |
Completed |
Study Name: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome Condition: Lambert-Eaton Myasthenic Syndrome Date: 2000-02-24 Interventions: Drug: 3,4-diaminopyridine |